Diagnosis remains the primary bottleneck in achieving Global Health Sector Strategy  

Global elimination of HCV requires a coordinated effort to prevent new infections while simultaneously curing existing infections. “In 2017, the global prevalence of HCV dropped to 69.6 (61.4 - 78.1) million viremic infections (a prevalence of 0.9%, 0.8%-1.0%), due to increased treatment and prevention efforts,” says Sarah Blach. Diagnosis, however, remains the primary bottleneck in achieving the interim (2020) Global Health Sector Strategy (GHSS) targets. Between 2018 and 2020, 1.9 million patients need treatment annually, and 4.3 million patients need to be newly diagnosed annually to achieve the targets of 30% diagnosed and a 10% reduction in mortality. According to Ms. Blach, in the long term (2020-2030), diagnosis and treatment become equally important, with annual diagnosis of 4.5 million patients and annual treatment of just over 5 million patients needed to achieve the elimination target.

Polaris Observatory was developed by:  
Made possible through funding from:
John Martin Foundation

Copyright © polarisobservatory.com All rights reserved